Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Petmed Express (PETS) Stock Price & Analysis

879 Followers

PETS Stock Chart & Stats

$1.22-$0.02(-1.61%)
At close: 4:00 PM EST
$1.25$1.5$1.75$2Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$1.19 - $1.23
52-Week Range
$1.15 - $4.10
Previous Close
$1.24
Volume
N/A
Average Volume (3M)
99.51K
Market Cap
$26.45M
Enterprise Value
$28.97M
Total Cash (Recent Filing)
$13.08M
Total Debt (Recent Filing)
$414.00K
Price to Earnings (P/E)
―
Beta
1.51
Next Earnings
Nov 10, 2026 (Est.)
EPS Estimate
-0.11
Last Dividend Ex-Date
Aug 11, 2023
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Recurring Revenue Mix

A higher recurring-sales mix can make revenue more predictable and strengthen customer retention, particularly for routine pet medications and preventative treatments. This supports more efficient marketing, improves visibility into future demand, and can provide a stronger foundation for eventual profitability.

Low Leverage

Minimal debt limits interest burdens and reduces refinancing pressure while the company works to restore profitability. The relatively unlevered balance sheet preserves financial flexibility for operations, technology investment, and customer growth without the constraints associated with substantial borrowing.

Operating Efficiency And Reach

Lower customer-acquisition costs indicate more productive marketing, while the Rural King white-label launch expands distribution beyond PetMeds’ core channel. Together, these initiatives can improve customer economics and broaden reach if the partnership generates repeat purchases over time.

Bears Say

Revenue Decline

A substantial decline in prescription revenue weakens the company’s core sales base and makes fixed operating costs harder to absorb. Continued softness would limit scale benefits, pressure cash generation, and require sustained execution in retention, marketing, and newer growth channels.

Persistent Losses And Cash Burn

Ongoing operating and free-cash outflows show that the business is not currently funding itself internally. Persistent cash consumption can reduce financial resilience, constrain investment in growth initiatives, and increase reliance on cash reserves or planned financing actions if profitability does not improve.

Weak Operating Profitability

Worsening adjusted EBITDA despite lower operating expenses indicates that cost reductions have not yet overcome revenue and gross-profit pressure. Lower margin leaves less room to absorb competitive pricing, marketing needs, or fulfillment costs, delaying a durable return to positive earnings.

Petmed Express News

PETS FAQ

What was Petmed Express’s price range in the past 12 months?
Petmed Express lowest stock price was $1.15 and its highest was $4.10 in the past 12 months.
What is Petmed Express’s market cap?
Petmed Express’s market cap is $26.45M.
When is Petmed Express’s upcoming earnings report date?
Petmed Express’s next earnings report is estimated for Nov 10, 2026 (not yet confirmed), which is in 1 day.
How were Petmed Express’s earnings last quarter?
Petmed Express released its earnings results on Aug 13, 2026. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of $0.12 by -$0.4.
Is Petmed Express overvalued?
According to Wall Street analysts Petmed Express’s price is currently Undervalued.
Does Petmed Express pay dividends?
Petmed Express pays a Quarterly dividend of $0.3 which represents an annual dividend yield of ―. See more information on Petmed Express dividends here
What is Petmed Express’s EPS estimate?
Petmed Express’s EPS estimate is -0.11.
How many shares outstanding does Petmed Express have?
Petmed Express has 21,678,913 shares outstanding.
What happened to Petmed Express’s price movement after its last earnings report?
Petmed Express reported an EPS of -$0.28 in its last earnings report, missing expectations of $0.12. Following the earnings report the stock price went down -10.099%.
Which hedge fund is a major shareholder of Petmed Express?
Hedge funds hold Petmed Express shares: the largest hedge-fund position in Petmed Express is 71,886,192 shares, and hedge funds decreased their holdings by 498.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology